The effect of adolescent marijuana use on brain development remains unclear despite relaxing legal restrictions, decreased perceived harm, and increasing use rates among youth. The aim of this 3-year prospective study was to evaluate the long-term neurocognitive effects of adolescent marijuana use. Method: Adolescent marijuana users with concomitant alcohol use (MJ ϩ ALC, n ϭ 49) and control teens with limited substance use histories (CON, n ϭ 59) were given neuropsychological and substance use assessments at project baseline, when they were ages 16 -19. They were then reassessed 18 and 36 months later. Changes in neuropsychological measures were evaluated with repeated measures analysis of covariance (ANCOVA), controlling for lifetime alcohol use, and examined the effects of group, time, and group by time interactions on cognitive functioning. Results: MJ ϩ ALC users performed significantly worse than controls, across time points, in the domains of complex attention, memory, processing speed, and visuospatial functioning (ps Ͻ.05). Earlier age of marijuana use onset was associated with poorer processing speed and executive functioning by the 3-year follow-up (ps Յ.02). Conclusions: Frequent marijuana use throughout adolescence and into young adulthood appeared linked to worsened cognitive performance. Earlier age of onset appears to be associated with poorer neurocognitive outcomes that emerge by young adulthood, providing further support for the notion that the brain may be uniquely sensitive to frequent marijuana exposure during the adolescent phase of neurodevelopment. Continued follow-up of adolescent marijuana users will determine the extent of neural recovery that may occur if use abates.
. Prospective investigations of adolescent marijuana users will help clarify cognitive trajectories associated with adolescent use and the longer-term neurocognitive implications.
The high rates of marijuana and alcohol use among adolescents is of great concern because ongoing neurodevelopment occurs throughout adolescence and emerging adulthood (Gogtay et al., 2004; Tamnes et al., 2010) , and exposure to neurotoxic compounds during this period may alter healthy brain development (Squeglia, Jacobus, & Tapert, 2009 ). White matter tissue volume and density increases in a linear fashion through the second and third decades of human life, whereas region-specific cortical gray matter volume increases and subsequently declines (Giedd et al., 1999; Jernigan, Trauner, Hesselink, & Tallal, 1991; Reiss, Abrams, Singer, Ross, & Denckla, 1996; Sowell et al., 2003) . Over the past two decades, the advent of more sophisticated neuroimaging techniques has allowed researchers to identify functional and structural brain abnormalities in cerebral gray and white matter associated with heavy marijuana and alcohol use during adolescence (Batalla et al., 2013; Lorenzetti, Solowij, Fornito, Lubman, & Yucel, 2014) . Included in these abnormalities are atypical morphometry and neurocognitive correlates in the hippocampus , prefrontal cortex (Medina et al., 2009) , and cerebellum (Medina, Nagel, & Tapert, 2010) ; disruptions in white matter integrity observed as increased diffusivity and decreased anisotropic diffusion, particularly in fronto-temporal and fronto-parietal pathways Jacobus, McQueeny et al., 2009; ; and altered functional brain networks, including increased frontal and parietal activation during verbal learning and spatial working memory tasks, suggesting potential compensatory neural recruitment to maintain task performance (Schweinsburg et al., 2005; Schweinsburg et al., 2010; Schweinsburg, Schweinsburg, Nagel, Eyler, & Tapert, 2011; Tapert et al., 2004) .
Alcohol and marijuana use during adolescence have also been linked to cognitive deficits. Heavy drinking during adolescence has been consistently associated with neuropsychological impairment in many cognitive domains, including attention and information processing Tarter, Mezzich, Hsieh, & Parks, 1995) , executive functioning (Giancola, Shoal, & Mezzich, 2001; Moss, Kirisci, Gordon, & Tarter, 1994) , visuospatial functioning (Sher, Martin, Wood, & Rutledge, 1997; Squeglia, Spadoni, Infante, Myers, & Tapert, 2009) , and verbal and nonverbal retention (Brown, Tapert, Granholm, & Delis, 2000) . While the deleterious effects of heavy alcohol use during adolescence have been well documented, the cognitive sequelae of adolescent marijuana use are less well understood . Within several hours to days of last use, heavy marijuana using adolescents and young adults have demonstrated deficits in attention, verbal learning and memory, psychomotor speed, and sequencing functioning (Fried, Watkinson, & Gray, 2005; Hanson et al., 2010; Harvey, Sellman, Porter, & Frampton, 2007; Solowij et al., 2011) . Cognitive deficits may also persist after longer periods of abstinence (Bosker et al., 2013; Hanson et al., 2010) . For example, adolescent marijuana users continue to show attention, verbal story memory, psychomotor speed, and sequencing deficits after approximately 1 month of abstinence . Evidence further suggests that adolescent onset (initiation prior to age 16, approximately) is an important risk factor and predicts poorer neural health and neurocognitive outcome over time (Gruber, Dahlgren, Sagar, Gönenc, & Lukas, 2014; Gruber, Sagar, Dahlgren, Racine, & Lukas, 2012; Pope et al., 2003; Solowij et al., 2011; Zalesky et al., 2012) . Meier and colleagues found that adolescent-onset cannabis users demonstrated IQ declines persisting years following cessation of use (Meier et al., 2012) . While some longitudinal studies suggest deficits in processing speed and memory do not persist beyond several weeks of abstinence, most acknowledge that age of marijuana use onset likely increases vulnerability to longerterm effects (Fried et al., 2005; Pope et al., 2003; Pope, Gruber, Hudson, Huestis, & Yurgelun-Todd, 2001; Tait, Mackinnon, & Christensen, 2011) .
Despite the prevalence of teenagers using marijuana, consistent evidence documenting cognitive sequelae are lacking. To date, few prospective studies have examined the longer-term neuropsychological consequences of marijuana use during adolescence with a comprehensive test battery (Fried et al., 2005; Meier et al., 2012; Tapert, Granholm, Leedy, & Brown, 2002) . This study builds on previous work from our group ; Jacobus, ). Our original cross-sectional neuropsychological investigation found that adolescent marijuana users performed worse than nonusers on psychomotor speed, attention, and memory performance at baseline . Cross-sectional investigations with this sample have also focused on neuroimaging markers, such as white matter integrity and the corresponding neurocognitive correlates (Bava, Jacobus, Mahmood, Yang, & Tapert, 2010) . Subsequent longitudinal work added follow-up neuroimaging data and evaluated neurocognitive differences in smaller (e.g., N ϭ 54) subsamples Jacobus, Squeglia, Infante, Bava, & Tapert, 2013; . This study builds on this work by focusing exclusively on neurocognitive data obtained at three time points (N ϭ 108). The primary goal was to investigate the long-term impact of adolescent marijuana use on cognition. We hypothesized that adolescent marijuana users would demonstrate poorer neurocognitive performance across multiple domains than nonusers at baseline, 1.5-year, and 3-year follow-up. We further suspected that early onset marijuana users (initiation of regular use before 16 years of age) would demonstrate worse cognitive performance than late-onset users.
Method Participants
Adolescents (N ϭ 108; ages 16 -19 at baseline) were recruited from San Diego area schools and followed for 3 years, which included a baseline and follow-up 1.5 and 3 years later, each with comprehensive substance use and neuropsychological assessments administered by a trained bachelor's or master's level research assistant. All participants underwent written informed consent (or assent if under age 18 and consent from their guardians) in accordance with the University of California, San Diego Human Research Protections Program. Adolescents were classified at baseline as mari-juana users (with concomitant alcohol use) with Ն60 lifetime marijuana use episodes (MJ ϩ ALC, n ϭ 49), or control teens with Յ9 lifetime marijuana use episodes and minimal alcohol use (CON; Table 1, Figure 1 ). At baseline, reported drinks per month ranged from 0 -248 for MJ ϩ ALC and 0 -58 for CON, and cigarettes per day ranged from 0 -10 for MJ ϩ ALC and 0 -1 for CON (Table 1, Figure 1 for more detailed substance use characteristics). Marijuana users in our study are relatively consistent in their marijuana use patterns as over 80% continue to report Ͼ60 marijuana use episodes per year by 3-year follow-up. Similarly, marijuana users engage in consistent alcohol use, as 96% report Ͼ150 lifetime alcohol use episodes by age 20. Only 22% report fewer than 10 drinks per month by 3-year follow-up, and 16% deny heavy episodic drinking behaviors (Ն4 drinks on one occasion for females and Ն5 drinks for males).
Exclusionary criteria at study entry included the following: history of a lifetime Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) Axis I disorder (other than cannabis or alcohol abuse/dependence), history of learning disability, history of neurological disorder or traumatic brain injury with loss of consciousness Ͼ2 min, history of a serious physical health problem, complicated or premature birth including prenatal substance use, uncorrectable sensory impairments, left handedness, and use of psychoactive medications.
Participants underwent biweekly urine toxicology for 4 weeks prior to cognitive assessments to confirm self-report of substance use at each time point and encourage abstinence from marijuana to avoid capturing the acute adverse effects of recent use. Compliance with the abstinence protocol is associated with decreasing 9-carboxy-tetrahydrocannabinol (THCCOOH)/cre- atinine excretion ratios. New cannabis use was determined by dividing each THCCOOH normalized collection by the previously collected specimen (urine 2/urine 1), per Huestis and Cone recommendations for determining new cannabis use as a function of time (Huestis & Cone, 1998; Smith, Barnes, & Huestis, 2009 ). Most participants reported at least 3 weeks of abstinence (self-report corroborated with decreasing excretion ratios) at each time point (89% at baseline and 70% at 1.5-and 3-year follow-up), and 13 reported Ͻ1 week of abstinence prior to assessment at 3-year follow-up (minimum was the day before testing).
Measures
Neuropsychological battery. Standardized neuropsychological tests within the well-established domains of complex attention, processing speed, verbal memory, visuospatial functioning, and executive functioning Lezak, Howieson, & Loring, 2004; included the following: (1) complex attention: California Verbal Learning Test-II (CVLT-II) Trial 1 total words and Trial 1-5 total words (Delis, Kramer, Kaplan, & Ober, 2001 ); Wechsler Adult Intelligence Scale Third Edition (WAIS-III) Arithmetic total and Digit Span forward, backward, and total scores (Wechsler, 1997b) ; and the Paced Auditory Serial Addition Test (PASAT) 2-s trial total score (Gronwall, 1977) ; (2) processing speed: WAIS-III Digit Symbol Coding total score (Wechsler, 1997b) ; and the Delis-Kaplan Executive Functioning System (D-KEFS) Trail Making Test (TMT) Visual Scanning, Number Sequencing, Letter Sequencing, and Motor Speed total time to completion (Delis & Kaplan, 2000) ; (3) verbal memory: Wechsler Memory Scale Third Edition (WMS-III) Logical Memory I, II, and Recognition total score (Wechsler, 1997a) ; and CVLT-II Short and Long Delay Free and Cued Recall total words and Recognition Discriminability z-score (Delis et al., 2001) ; (4) visuospatial functioning: Wechsler Abbreviated Scale of Intelligence (WASI) Block Design total score (Wechsler, 1999) ; copy and delay accuracy conditions of the Rey Osterrieth Complex Figure ( and Tower Test total achievement score (Delis & Kaplan, 2000) .
Both raw scores (to increase variability) and age-corrected scaled scores (e.g., CVLT-II, WAIS-III, WASI, D-KEFS, WMS-III) were examined and reported for each subtest if significant. It is important that groups did not differ in age at any time point. Data were available for all participants, except 4 cases (2 from each group) did not receive CVLT-II and D-KEFS tasks at 3-year follow-up (CON, n ϭ 57; MJ ϩ ALC, n ϭ 47), 1 did not receive the WASI Block Design subtest at baseline (MJ ϩ ALC, n ϭ 48), 2 did not receive the PASAT at 1.5-year follow-up (CON, n ϭ 57), and 6 (2 at 1.5-year follow-up and 4 at 3-year follow-up) did not receive the Complex Figure ( MJ ϩ ALC, n ϭ 43); therefore, these individuals were excluded from the subtest analysis for which data were missing.
Substance use and mental health assessment. The Customary Drinking and Drug Use Record (CDDR) assessed quantity and frequency of lifetime alcohol, marijuana, cigarette, and other illicit drugs (Brown et al., 1998) , including amphetamines, hallucinogens, cocaine, opiates, benzodiazepines, ecstasy, ketamine, and gamma-hydroxybutyrate (GHB). The Timeline Followback collected data on self-reported substance use in the past 28 days prior to cognitive assessment (Sobell & Sobell, 1992) . The Beck Depression Inventory and the State Trait Anxiety Inventory (STAI) assessed depression symptoms and state anxiety at each visit (Beck, 1978; Spielberger, Gorsuch, & Lushene, 1970) .
Data Analysis
Group comparisons. Analysis of variance and chi-square tests were used to examine between group differences in demographic characteristics. Repeated-measures analyses of covariance (ANCOVA) were used to examine the trajectories of neuropsychological performance for each neuropsychological subtest identified within each domain. The main effects of time, group status at baseline, and group by time interactions were specified for each ANCOVA and run with lifetime alcohol use as a covariate given the high rate of alcohol use reported by the marijuana users. Multivariate results are reported for each ANCOVA unless homogeneity of variance assumptions were violated, in which case Greenhouse-Geisser corrections were applied. If an effect of group or group by time interaction was found to be significant (p Ͻ .05), the simple effects were explored with lifetime alcohol use as a covariate; the ANCOVA analysis was also rerun dividing the substance users (MJ ϩ ALC) into early (Ͻ16 years old, n ϭ 27) and late (Ն16, n ϭ 22) onset of regular marijuana use (consistent with previous studies), defined as initiation of regular marijuana use Ͼ1x/week for 52ϩ weeks (Ehrenreich et al., 1999; Gruber et al., 2014; Gruber, Silveri, Dahlgren, & Yurgelun-Todd, 2011) .
Bivariate correlations. Correlations were explored in the larger sample (N ϭ 108) between neuropsychological performance at 3-year follow-up, depression scores at 3-year followup, and state anxiety scores at 3-year follow-up. Within the substance use group (n ϭ 49), correlations were explored between neuropsychological performance at 3-year follow-up and age of onset of regular marijuana and alcohol use (defined as Ͼ1x/week for 52ϩ weeks), lifetime marijuana and alcohol use, and recency of marijuana and alcohol use at 3-year followup. For significant bivariate relationships identified, hierarchical linear regressions were run predicting neurocognitive performance at 3-year follow-up (dependent variable). To identify whether emotional functioning, age of onset of use, or substance use severity was a significant predictor of neurocognitive performance at Year 3 above and beyond baseline testing performance, the corresponding baseline neuropsychological performance was entered on Step 1 and the appropriate independent predictors on Step 2.
Results

Demographics
Groups did not differ on demographic measures, but the MJ ϩ ALC group had more substance use, as expected (Table 1, Figure 1 ). The early onset marijuana group reported initiating weekly marijuana use almost 3 years sooner than the late-onset heavy users, and regular alcohol use about 1 year earlier, but had no other significant demographic or substance use differences (Table 2, Figure 1 ). 
Complex Attention/Working Memory Tasks
The MJ ϩ ALC versus CON group by time interaction significantly predicted CVLT-II Trial 1 performance, raw scores; F(2, 100) ϭ 3.24 p ϭ .04. MJ ϩ ALC users remembered fewer words than controls at 1.5-year follow-up, F(1, 101) ϭ 8.33, p Ͻ .01, but the difference was no longer present at 3-year follow-up (p Ͼ .05). Similarly, the early (n ϭ 26) versus late MJ onset (n ϭ 21) group by time interaction predicted CVLT-II Trial 1 raw scores, F(3.7,188.6) ϭ 2.70, p ϭ .03. Specifically, the early MJ onset group remembered fewer words than controls at 1.5-year followup, F(2, 100) ϭ 4.51, p ϭ .01, but this was no longer the case at 3-year follow-up (p Ͼ .05; Table 3 , Figures 2 and 5) .
The MJ ϩ ALC versus CON main effect for group predicted WAIS-III Digit Span backward subtest performance, F(1, 105) ϭ 6.47, p ϭ .01. MJ ϩ ALC performed poorer than CON at baseline, F(1, 105) ϭ 5.01, p ϭ .02, 1.5-year follow-up, F(1, 105) ϭ 5.26, p ϭ .02, and 3-year follow-up, F(1, 105) ϭ 3.95, p ϭ .04. A main effect of group was also observed between early/late MJ onset versus CON, F(2, 104) ϭ 4.36, p ϭ .01, with the late onset group performing worse than CON at 1.5-year, F(2, 104) ϭ 3.73, p ϭ .02 and 3-year followups, F(2, 104) ϭ 3.50, p ϭ .03 (Table 3, Figures 2 and 5) .
A MJ ϩ ALC versus CON trend for main effect of group was observed for Digit Span total raw score; MJ ϩ ALC users showed poorer performance than CON, F(1, 105) ϭ 3.28, p ϭ .07 at baseline and 1.5-year follow-up (ps ϭ .07). The late MJ onset users performed worse than early onset users and controls, F(2, 104) ϭ 2.81, p ϭ .06, at 3-year follow-up (ps ϭ .02). Trends were also seen for a MJ ϩ ALC versus CON group main effect for Arithmetic scaled scores, F(1, 105) ϭ 3.16, p ϭ .07, and a group by time interaction for PASAT total score, F(2, 102) ϭ 2.6, p ϭ .07. MJ ϩ ALC performed poorer than CON at 1.5 and 3-year follow-up on PASAT total correct (ps Ͻ.05; Table 3 , Figures 2 and 5 ).
Verbal Memory Tasks
MJ ϩ ALC versus CON, F(1, 105) ϭ 5.67, p ϭ .01, and early/late MJ onset versus CON main effects of group, F(2, 104) ϭ 3.31, p ϭ .04, significantly predicted WMS-III Logical Memory I (immediate recall) scaled scores. Follow-up analyses revealed that MJ ϩ ALC showed poorer performance than CON at 1.5 year, F(1, 105) ϭ 5.75, p ϭ .01, and 3-year follow-ups, F(1, 105) ϭ 5.74, p ϭ .01. Early MJ onset users showed poorer performance (p ϭ .01) than CON at 3-year follow-up (Table 3, Figures 3 and 5) . MJ ϩ ALC versus CON, F(1, 105) ϭ 11.44, p Ͻ .01, and early/late MJ onset versus CON main effects of group, F(2, 104) ϭ 6.04, p Ͻ .01, significantly predicted WMS-III Logical Memory Recognition scores. Follow-up analysis showed that MJ ϩ ALC performed worse than CON at baseline , F(1, 105) ϭ 4.57, p ϭ .03,  1.5 year, F(1, 105) ϭ 6.36, p ϭ .01, and 3-year follow-ups, F(1,  105) ϭ 12.32, p Ͻ .01. Early MJ onset users correctly identified fewer words than CON at baseline (p ϭ .01) and 1.5-year follow-up (p ϭ .02); CON identified more words than both early and late MJ onset users at 3-year follow-up (ps Ͻ .01; Figure 2) . A trend for a MJ ϩ ALC versus CON main effect of group was seen for WMS-III Logical Memory II scaled scores (delayed recall), F(1, 105) ϭ 3.12, p ϭ .08, with CON showing better performance at 1.5-year follow-up, F(1, 105) ϭ 3.37, p ϭ .06 (Table 3 , Figures 3 and 5 ).
Processing Speed Tasks
A trend was observed for a MJ ϩ ALC versus CON main effect of group on WAIS-III Digit Symbol Coding scaled scores, F(1, 105) ϭ 3.24, p ϭ .07; however, the early/late MJ onset versus CON main effect of group was significant, F(2, 104) ϭ 3.25, p ϭ .04. CON performed better than early MJ onset users at 1.5-year follow-up (p ϭ .01; Table 3 , Figures 4 and 5) .
Visuospatial Functioning Tasks
The MJ ϩ ALC versus CON group by time interaction significantly predicted the Complex Figure copy condition, F(2, 98) ϭ 3.45, p ϭ .03. We saw improvement in CON performance from baseline to 3-year follow-up, but a significant decline and subsequent improvement in MJ ϩ ALC performance from baseline to 1.5-year follow-up and 1.5-year follow-up to 3-year follow-up (ps Ͻ .01). A trend for the early/late MJ onset group versus CON interaction effect was observed, F(4, 194) ϭ 2.34, p ϭ .05. CON improved in their performance from baseline to 3-year follow-up, whereas both the early/late onset groups decreased and then improved in their performance (ps Ͻ .01; Table 3 , Figures 4 and 5) .
Executive Functioning Tasks
We did not observe any main effects of group, or group by time interactions (or trends) in the domain of executive functioning (Table 3, Figure 5 ).
Within-Subjects Effects
In addition to the group main effects reported previously, a main effect of time (increasing performance from baseline to follow-up) was found for the vast majority of measures as anticipated (20 of 26 tests), controlling for lifetime alcohol use, including CVLT-II Trials 
Bivariate Correlations
There are significant relationships in the larger group (N ϭ 108) between state anxiety T score and WAIS-III Digit Symbol performance (raw and scaled scores), rs ϭ Ϫ.21, ps ϭ .02, Trail Making Test Number Sequencing condition raw scores, r ϭ .20, p ϭ .04, and CVLT-II Short Delay Cued Recall, r ϭ Ϫ.20, p ϭ .04. We did not see significant relationships between cognitive performance and depression, recency of substance use, or lifetime marijuana use and lifetime alcohol use.
In Figure 6 ).
Hierarchical linear regressions were run predicting WAIS-III Digit Symbol and Trail Making Test performance (scaled scores), with baseline performance entered on the first step (and anxiety T score for prediction of Digit Symbol performance), and age of marijuana use onset on the second step. For Trail Making Test Number Sequencing and Switching, age of marijuana onset was found to be a significant predictor (␤ ϭ Ϫ.49 p Ͻ .01; ␤ ϭ Ϫ.33 p ϭ .01) and accounted for variance above and beyond baseline test performance, F(2, 43) ϭ 12.77, p Ͻ .01, ⌬R 2 ϭ .23, p Ͻ .01; F(2, 43) ϭ 7.2, p Ͻ .01, ⌬R 2 ϭ .12, p ϭ .01 Age of onset (␤ ϭ Ϫ.06, p ϭ .57) was not found to be a significant predictor of performance beyond baseline performance and anxiety T score (␤ ϭ .24 p ϭ .02) for Digit Symbol performance, or Trail Making Test Visual Scanning (␤ ϭ .18 p ϭ .19) and Letter Sequencing (␤ ϭ .21 p ϭ .18).
Discussion
This study evaluated adolescents reporting heavy marijuana and alcohol use and control teens with minimal substance over 3-years. Group differences, controlling for lifetime alcohol use, were observed in the domains complex attention, memory, processing speed, and visuospatial functioning. While MJ ϩ ALC performed worse than controls across all three time points, significant differences were more consistent at 19 years old (1.5-year follow-up) across domains, just prior to a narrowing substance use gap observed by age 20 (3-year follow-up) between our users and controls for both alcohol and marijuana use. Our sample use trajectories are consistent with epidemiological research that shows marijuana use tends to peak around 18 -19 years old in the United States (spanning baseline to 1.5-year follow-up) for those who do not transition to chronic heavy use (Caldeira et al., 2012; Johnston et al., 2014) . Poorer cognitive performance in our users (at 1.5-year follow-up) compared with those with more minimal use histories corresponds with the epidemiological literature on age of peak use, and differences are observed in domains important for optimal cognitive performance.
It is important to put these findings into the context of the broader marijuana literature by exploring (a) how these findings compare to other cross sectional and longitudinal work, and (b) the mechanism likely driving observed group differences in this study and others. Cross-sectional studies have found group differences (nonacute) between adolescent/young adult marijuana users and controls across neurocognitive domains. For example, studies that have required at least 24 hr of abstinence find that adolescent and young adult marijuana users do not perform as well as matched controls on processing speed, attention, and memory tasks (Bartholomew, Holroyd, & Heffernan, 2010; Gonzalez et al., 2012; Hanson et al., 2010; Takagi et al., 2011) , and executive functioning and inhibition tasks (Griffith-Lendering, Huijbregts, Vollebergh, & Swaab, 2012) . Dose-dependent relationships have identified increased lifetime marijuana use associated with poorer processing speed, memory, and executive functioning in adolescents and young adults, which may be moderated by gender Lisdahl & Price, 2012) . Our findings show performance discrepancies in domains overlapping with the existing literature and independently measured over the course of three years.
Longitudinal work, while still limited, also finds poorer neurocognitive outcomes associated with adolescent marijuana use. Meier and colleagues (2012) found that those with persistent cannabis use histories over a 20-year period showed widespread decline in areas such as memory, processing speed, and executive functioning from their premorbid childhood functioning (ages 7-13). However these individuals were not assessed throughout adolescence and likely represent the consequences of more severe and pervasive use patterns established by young adulthood (age 38), versus elucidating the cognitive sequelae of "subdiagnostic" use increasing in prevalence during adolescence Meier et al., 2012) . While our observed group differences are subtler in nature, and widespread decrements in performance are not observed across all subtests, there remains evidence for adverse effects of use throughout the transition from adolescence to young adulthood on select aspects of neurocognitive functioning. As marijuana use differences gradually decrease between our groups, we see slightly fewer significant group differences by 3-year follow-up, which may speak to the possibility of "recovery" or resolving effects in some domains. Other longitudinal studies that have utilized a comprehensive test battery include research by Fried and colleagues (2005) who found that former heavy users by ages 17-21 (no regular use for at least three months) did not differ on a comprehensive neuropsychological battery compared with nonusing controls. Current heavy users differed in memory and processing speed performance after accounting for preexisting differences.
Continued follow-up of longitudinal cohorts is greatly needed to assess the degree of enduring effects. Strong dose-dependent relationships with lifetime use and recency of use were not identified in this study. However, abstinence was encouraged with 4 weeks of monitored toxicology (abstinence ranged 1 day to several years by 3-year follow-up), and most did not use within the week of testing (or longer), potentially washing out recency effects as reported in other studies (Solowij et al., 2011) .
We saw associations between earlier age of onset and poorer processing speed and executive functioning performance as measured by several conditions on the D-KEFS Trail Making Test. Notably, age of onset was found to predict Number Sequencing and Switching 3-year follow-up performance above and beyond baseline performance. Several studies have identified poorer outcomes associated with earlier age of marijuana use onset (regular use before age 16), including poorer reaction time (RT) performance (Ehrenreich et al., 1999) , executive functioning (e.g., Stroop Color Word Test, Wisconsin Card Sorting Test; Fontes et al., 2011; , memory performance (Solowij et al., 2011; Solowij et al., 2012) , and verbal abilities (Pope et al., 2003) . Neuroimaging studies have also found that earlier age of marijuana use onset is associated with altered neural tissue health in gray and white matter and functional brain activation patterns (Becker, Wagner, Gouzoulis-Mayfrank, Spuentrup, & Daumann, 2010; Gruber, Dahlgren, Sagar, Gönenc, & Killgore, 2012; Gruber et al., 2014; Wilson et al., 2000) . Taken together, our study expands on these findings and provides more evidence that encouraging delayed initiation of cannabis is advantageous, because earlier initiation is likely to have negative neural consequences.
In our sample, our late MJ onset group reports more recent marijuana use, on average, at 3-year follow-up. While the late onset group reports slightly more marijuana use per month at baseline and 1.5-year follow-up, differences in monthly marijuana use are no longer evident a 3-year follow-up between our early- and late MJ onset groups. This is likely related to our late MJ initiation group (initiation after age 16) starting to use more regularly around the baseline time point (ϳage 18). In attention performance, we see the early and late MJ onset groups performing more poorly compared with controls. While speculative, differences observed between the late MJ onset group and controls may represent recency of use to some degree, given that in some domains (i.e., processing speed) relationships with late onset are not observed; however, in domains shown to be influenced by recency of use (i.e., attention; Bosker et al., 2013; Hanson et al., 2010; Solowij et al., 2011) , the late MJ onset users perform poorly compared with controls. The early MJ onset group demonstrated poorer performance at 1.5-year follow-up, but not 3-year followup, on CVLT-II Trial 1 and Digit Symbol Coding subtests. Considering the early MJ onset group reports more drinks per month and less occasions at 1.5-year follow-up, it is possible that pattern of alcohol use at this time point may have contributed to this finding despite lifetime alcohol use included as a covariate in all analyses.
There are several outstanding questions that need to be addressed in the adolescent cannabis literature, including the degree to which preexisting differences account for any between group differences observed (Cheetham et al., 2012; Fried et al., 2005; Jacobus, Squeglia, Infante, Bava, and Tapert (2013) ; Meier et al., 2012) ; how changing use trajectories over discrete adolescent and young adult periods of development impact neural and cognitive outcomes, particularly in the domains of attention, memory, and processing speed; and how unique relationships with co-occurring use (e.g., alcohol) impact neural outcomes Mahmood, Jacobus, Bava, Scarlett, & Tapert, 2010) . Despite the limited dose-dependent alcohol findings observed in the present study (i.e., bivariate relationships with lifetime alcohol use), we have seen divergent relationships with alcohol and mar- ijuana use in other investigations in our laboratory (Jacobus, Squeglia, Sorg, Nguyen-Louie, & Tapert, 2014) .
The biological mechanisms that may underlie neurocognitive differences include a marijuana-related toxic impact (e.g., neuroinflammatory response) on the vulnerable developing brain, or altered development trajectories that result from reorganization of the endocannabinoid system, which is critical for development and modulation of several neurotransmitter systems and normal neuromaturation (Atakan, 2012; Cutando et al., 2013; Iversen, 2003; Rubino & Parolaro, 2008; Stella, 2013; Viveros et al., 2012) . Interference with neurogenesis, plasticity, neural patterning, or any other neurobiological processes can lead to poorer behavioral outcomes, including increased risk-taking behavior and poorer mental health functioning by young adulthood (Caldeira et al., 2012; Jacobus, Thayer, et al., 2013; Suárez-Pinilla, López-Gil, & Crespo-Facorro, 2014; Terry-McElrath, O'Malley, & Johnston, 2014) . Recent reviews of neural effects of cannabis use have corroborated many findings from our laboratory, including decreased hippocampal volume (Lorenzetti et al., 2014; , decreased white matter integrity in fronto-thalamic connections (Batalla et al., 2013; Bava et al., 2009; Jacobus, Squeglia, Infante, et al., 2013) , and different activation patterns in frontal cortices (Batalla et al., 2013; Schweinsburg et al., 2011) . Alterations, even subtle, in in these critical brain systems may result in marijuana users at a neurocognitive disadvantage resulting in decreased performance in several neurocognitive domains (e.g., attention, memory) reported in this study, despite less consistent evidence for associations between neurocognitive functioning and neuroimaging markers of structural brain integrity (Lorenzetti et al., 2014) Limitations include the lack of preexisting neuropsychological data for this cohort. Unfortunately the suggestion that the observed differences existed prior the initiation of substance use in our sample cannot be ruled out, despite prospective (pre/post initiation) evidence of a marijuana-related effect on neurodevelopment (Jacobus, Squeglia, Infante, et al., 2013) . There may be biological and environmental factors present prior to marijuana initiation and contributing to marijuana use and cognitive vulnerabilities. These findings need to be expanded upon and replicated, as our effect sizes and Type I error control was modest. We took measures to decrease the practice effects on our repeated neuropsychological measures, particularly for tasks in which salience of stimuli were most likely to carry over from one assessment to another. While we recognize using different stimuli for the complex figure could systematically affect participants' performance, several studies have supported the equivalence of these measures (Delaney, Prevey, Cramer, Mattson, the VA Epilepsy Cooperative Study #264 Research Group, 1992; Strauss & Spreen, 1990; Tombaugh & Hubley, 1991) .
Our groups were matched on gender; however, gender differences in the relationships between cannabis use and neural functioning is becoming a growing area of research, and future work in our lab will focus on modeling these unique and complex relationships with larger sample sizes to identify whether substance use and neurocognitive associations exist similarly for both genders (Crane, Schuster, Fusar-Poli, & Gonzalez, 2012; . Self-reported alcohol and marijuana use continues to be a limitation of substance use research in general, and better objective measures of cannabis use may reduce inconsistencies in the re-search literature. Collecting additional information in future studies such as cannabis potency and content (e.g., THC/CBD ratios) will also help disentangle existing discrepancies. Furthermore, co-occurring alcohol and marijuana use is common and consistent with epidemiological data (Agosti et al., 2002; Johnston et al., 2014) . Marijuana users observed in this study tend to remain consistently heavy users of alcohol and marijuana use (Figure 1) . In fact, 96% of our marijuana users reported more than 150 lifetime alcohol use episodes by age 20. Only 22% report less than 10 drinks per month by 3-year follow-up, and few (16%) deny heavy episodic drinking behaviors. Nevertheless, it is possible that subtle changes in alcohol use patterns (vs. cumulative lifetime use) not captured in our data impact neurocognitive outcomes. Future work will examine interactions between differing use patterns of these substances.
Research suggests that adolescent cannabis use impacts cognitive and neural functioning. While there is potential and some evidence for neural recovery after prolonged use, the short-term implications suggest deleterious effects on neural and psychosocial functioning. Future prospective research studies will work to better delineate the impact of cannabis use on different stages of development with better objective markers of use; efforts to understand the timeline for both impairment and recovery will guide prevention, safety, and intervention development.
